Introduction
Hypertension is one of the leading causes of cardiovascular morbidity and mortality in Western society. [1] [2] [3] [4] It is associated with increased risk of stroke, myocardial infarction, congestive heart failure, peripheral vascular disease and renal dysfunction. The benefits of antihypertensive therapy in patients with sustained hypertension (defined as Ͼ140/90 mm Hg) have been demonstrated in a number of large randomised controlled trials. 4, 5 The HOT study 5 showed benefits is lowering diastolic blood pressure (BP) down to 82.6 mmHg, and in those patients with diabetes mellitus there was a marked reduction (51%) in major cardiovascular events in mate lower diastolic BP, and displayed poor reliability (P Ͻ 0.05). Despite meeting AAMI guidelines, only 59% of systolic and 56% of diastolic Dinamap readings were within 5 mm Hg of the mercury manometer and 84% of systolic and 80% of diastolic readings were within 10 mm Hg (BHS grade C). Systolic and diastolic accuracy were worse with pressures Ͼ160/90 mm Hg (grade D) although these measures were based on a smaller sample of subjects. In conclusion the Dinamap yields inaccurate estimates of both systolic and diastolic BP even under standardised, and thus optimal conditions. This inaccuracy is exaggerated at higher BP (Ͼ160/90 mm Hg), although the number of measurements at higher pressures was small. We recommend that this device not be used when accurate BP measurement is needed for therapeutic decision-making. those with a target Յ80 mm Hg compared with those with a target Յ90 mm Hg. 5 Accurate BP measurement is therefore essential for hypertension detection and follow-up, as a change of 5 mm Hg in either systolic or diastolic pressure can alter decisions regarding hypertensive therapy.
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Several automated devices are currently used for measuring BP non-invasively. The most common of these rely on oscillometric testing, in which a pizoelectric crystal measures arterial waveforms distal to a deflating cuff to obtain systolic and diastolic pressures. The cuff is inflated to higher than systolic pressure then deflated at a predetermined rate (usually 2-4 mm Hg/sec). Systolic BP is taken at the appearance of a pulsatile signal, while diastolic BP is calculated using a proprietary formula. 6 Although used frequently in hospital wards, emergency departments, operating theatres, intensive care facilities and outpatient settings, many automated devices have not undergone rigorous testing for accuracy or reliability. Both the American Associ-Journal of Human Hypertension ation of Medical Instrumentation (AAMI) and British Hypertension Society (BHS) have put forth standards for validating semi-automated and automated BP devices 7, 8 (Table 1) . Many devices have been found to be inaccurate on formal testing. [9] [10] [11] [12] [13] [14] The AAMI suggests that, for systolic and diastolic BP each considered separately, the mean difference between test devices (ie, Dinamp compared with mercury sphygmomanometer) be ±5 mm Hg or less, with a standard deviation of 8 mm Hg or less. The BHS describes a different method of evaluating automated BP devices, 15, 16 that uses a grading scheme based on repeated measures analysis. Only those devices that achieve a grade A or B for both systolic and diastolic measures are recommended for clinical use.
Studies of other automated BP devices have raised concerns about accuracy. In 1993, O'Brien et al 9 evaluated the Dinamap 8100 in 86 patients with a wide range of BP. The device received a BHS B grading for systolic BP, but only a D grading for diastolic BP (AAMI criteria were met only for systolic pressures). Accuracy deteriorated at higher pressures (Ͼ160/90 mm Hg). The authors therefore recommended that the Dinamap 8100 not be used for clinical circumstances where accuracy is desired. In 1996, Wattigney et al 10 evaluated the Dinamap 845 XT and Dinamap 8100 in 417 children as part of the Bogalusa Heart Study. They found that both oscillometric devices, and especially the 8100 model, underestimated diastolic BP. Accuracy was not described according to the BHS grading scheme. In 1998, Shuler et al 11 evaluated the IVAC 4200 model under standardised conditions and as routinely used by ward staff. Under standardised conditions, only 59% of systolic and 54% of diastolic readings were within 5 mm Hg of a mercury manometer standard (BHS grade C rating). When obtained by routine ward personnel only 40% of systolic and 50% of diastolic readings were within 5 mm Hg (BHS grades D and C respectively). The authors concluded that the IVAC 4200 yielded substandard estimates of systolic and diastolic BP even under standardised, thus optimal, conditions.
The current reference standard for non-invasive BP measurement is the mercury manometer. This device has been used extensively in therapeutic trials and health prevention studies, and has served in previous studies of other blood pressure monitors as the reference standard. 17, 18 We therefore decided to evaluate the accuracy and reliability of the Dinamap 1846 XT (Critikon Corporation, Tampa, FL, USA), a non-invasive oscillometric BP monitor common in our health district, using the mercury manometer reference standard. Measurements were obtained under standardised conditions, in medically stable hospital patients, by staff trained in BP measurement.
17,19

Methods
Subjects
Seventy-two patients admitted to a general medicine ward at Royal University Hospital were randomly selected for BP measurement, through blocked sampling of patient admission lists over a 16-week period. Patients were provided a brief explanation of the study, and gave verbal consent. Patients were excluded if they: (1) were clinically unstable, or (2) had an arm circumference outside of the available cuff sizes (14 -45 cm). Of the 72 patients approached, two were unable to complete all BP measurements because of cuff discomfort. Patient height, weight, arm circumference measured at the mid-humerus, pulse rate and regularity were recorded prior to BP determination. Admission ECGs were evaluated for arrhythmias.
Protocol
Six systolic/diastolic BP measurements were recorded for each patient, alternating between the Dinamap and the mercury manometer at 90-sec intervals. The initial device alternated consecutively with each patient. Therefore, a total of 210 measurements were obtained for each device.
Manual blood pressure measurements
Manual readings were simultaneously measured by two observers (EB, CC) trained in BP measurement. A standard portable mercury manometer and dual headed stethoscope were utilised. Results were recorded independently, in a blinded manner. Equipment was examined for defects in the outlet valve, tubing, bladder and cuff, as well as mercury column height. For all BP measurements, patients were supine with legs uncrossed, and resting for 5 min prior to examination. They could not eat, drink or smoke during this period or during BP measurement. Measurements were taken from the right arm (unless a medical condition precluded this -ie, A-V fistula, venous thrombosis, etc) with the relaxed arm slightly flexed and placed at heart level. Cuff size was selected according to arm circumference (small Ͻ22 cm, medium 22-33 cm, large Ͼ33 cm). Systolic BP was recorded at the appearance of two consecutive beats (Korotkoff phase I) and diastolic BP with disappearance of all auscultatory sounds (Korotkoff phase 5). Korotkoff phase 4 was recorded if phase 5 was Ͻ30 mm Hg.
Automated blood pressure measurements
Two separate Dinamap monitors were used throughout the study. Both were calibrated prior to the study by hospital technical staff and examined for defects in the cuff, bladder and tubing. The measurement protocol was similar to that used in manual BP measurement.
Statistical analysis
SPSS 8.0 (SPSS Inc. Chicago, IL, USA) was used for data analysis. Inter-observer reliability of paired manometer readings was evaluated using frequency distribution of difference 20 for all systolic and diastolic measures as described by the American National Standards Institute. 7, 8 Device reliability was assessed using repeated measures analysis of variance on the three sequentially paired mercury manometer and Dinamap measurements to assess absolute change over time. A graph of Dinamap error (difference between Dinamap and mercury manometer) vs an averaged Dinamap and mercury manometer pressure was created for all systolic and diastolic readings.
The Dinamap reliability was evaluated using repeated measures analysis for all systolic and diastolic BP as well as mean and standard deviation of difference between each Dinamap reading and the mercury manometer reading.
For the determination of Dinimap accuracy, true BP was assumed to be an average of both observers' mercury manometric readings.
Pre-specified subgroup analyses were also performed for patients with high BP (either systolic Ͼ160 mm Hg or diastolic Ͼ90 mm Hg), low (systolic Ͻ120 mm Hg and diastolic Ͻ70 mm Hg), or intermediate BP. Results were classified according to the BHS standards. 15, 16 The impact of patient size (arm circumference, weight, body mass index), heart rate, arrhythmia, and cuff size on device accuracy was assessed using analysis of variance, while independent sample t-test compared Dinamap accuracy within groups.
Results
Patient characteristics
A total of 70 patients were evaluated. Group characteristics are outlined in 
Reliability of reference standard
For the mercury manometer paired readings, 98% of systolic and 97% of diastolic were within 5 mm Hg of each other, while 100% of systolic and diastolic readings were within 10 mm Hg.
Dinamap reliability
Repeated measures analysis between values showed greater variance among Dinamap readings. The percentage of readings differing by more than 5 mm Hg between first and third systolic readings was 54% (95% confidence interval (CI), 42-66%) for the Dinamap compared to 28% (95% CI, 18-39%) for the mercury manometer (P Ͻ 0.05) while the percentage of readings differing by more than 10 mm Hg was 22% (CI, 13-32%) for the Dinamap and 10% (95% CI, 2.7-17%) for the mercury manometer (nonsignificant). The percentage of diastolic readings differing by more than 5 mm Hg between first and third readings was 34% (95% CI, 23-45%) for the Dinamap compared to 132% (95% CI, 5.1-20%) for the mercury manometer (P Ͻ 0.05), while the percent- age of readings differing by more than 10 mm Hg was 26% (95% CI, 16-36%) for the Dinamap and 4.3% (95% CI, −0.4 to 9%) for the mercury manometer (P Ͻ 0.05). There was no evidence of a systematic increase or decrease in readings over time.
Dinamap accuracy
To assess accuracy of the Dinamap, each oscillometric systolic and diastolic reading was compared with the corresponding averaged mercury manometer reading. The difference (Figures 1 and 2 ) between the Dinamap and averaged mercury manometer was then plotted against the mean of the two devices (ie, [Dinamap + mercury manometer] / 2). Across the measured blood pressures there was a slight upward trend for systolic values at higher blood pressures whereas diastolic values did not seem to vary. AAMI criteria were achieved for both systolic and diastolic values by the Dinamap (systolic: mean difference = 0 mm Hg, s.d. = 8 mm Hg, diastolic; mean difference = −3 mm Hg, s.d. 7.7 = mm Hg). However, for BHS criteria only 59% of systolic readings values were within 5 mm Hg, 84% within 10 mm Hg and 93% within 15 mm Hg of the mercury sphygmomanometer, for a grade C rating (Table 3) . For diastolic readings, 56% fell within 5 mm Hg, 80% within 10 mm Hg and 93% within 15 mm Hg. When accuracy was evaluated in low, intermediate and high BP subgroups the readings of both the low BP and the intermediate BP subgroups received grade C ratings, and the high BP subgroup readings merited only a D rating. The ratings did not change when we examined the first, second and third dinamap measurement separately.
For systolic hypertension (Ͼ140 mm Hg), the Dinamap false-negative rate was 6% (6/139) and false-positive rate 13% (9/71). For diastolic hypertension (Ͼ90 mm Hg), the false-negative rate was 3% (6/195) and false-positive rate 53% (8/15). We used analysis of variance and independent sample t-tests to assess factors associated with Dinamap accuracy. Systolic error (absolute value) was associated with increased weight and body mass index [r = 0.168, ␤ = 0.05, P = 0.015 where ⌬ = 0 at weight = 35.4 kg and r = 0.124, ␤ = 0.157, P = 0.012, where ⌬ = 0 at BMI = 13.6 kg/m 2 ]. However, these associations were weak. For instance a considerable increase of 10 kg/m 2 in body mass index would equate to an increase in absolute systolic error of only 1.6 mm Hg (ie, 10 × ␤ (0.157) = 1.57 mm Hg). In patients with pulse irregularity, mean systolic difference (± s.e.) between Dinamap and mercury manometer was −3.1 (±1. In patients with pulse irregularity mean diastolic difference (± s.e.) between Dinamap and mercury manometer was 3.2 (± 2.54) mm Hg vs −3.7 (±0.52) mm Hg (P = 0.01), and in patients with atherosclerotic heart disease −1.5 (±0.92) mm Hg vs −4.2 (±0.64) mm Hg (P = 0.015). There were no associations between diastolic error and other patient characteristics.
Discussion
In summary, we have examined the reliability and accuracy of the Dinamap 1846 XT automated BP monitor, using standard non-invasive BP measurement by mercury sphygmomanometer. We found the Dinamap 1846 XT to yield substandard estimates of both systolic and diastolic BP (BHS grade C), despite achieving AAMI standards. This inaccuracy was worse at high BP and in patients with increased body weight and body mass index. We found 11 of 210 (4%) of systolic readings were 16 or more mm Hg higher than true readings, while five (2%) were 16 or more mm Hg lower (Figure 1) .
We evaluated the Dinamap under standardised conditions only. Testing under 'real world' conditions may well have shown the Dinamap to be even less accurate and reliable; automated BP monitors have been shown to have even less accuracy when used by general ward personnel. 9 Under standardised conditions in this study, we used several readings over a short period of time, whereas repeated readings would be unusual in routine practice. We studied a range of medical patients, many of whom had hypertension, and/or complications of macrovascular disease, with broad ranges in both systolic and diastolic BP. We found that a sizeable number of diastolic measurements were misclassified as hypertensive, likely a result of the Dinamap overestimating diastolic pressures in the lower BP range.
Several factors may explain the inaccuracy of some oscillometric monitors. Some devices have cuff deflation rates exceeding 2 mmHg/sec, which tends to underestimate blood pressures and different proprietary algorithms are used by manufacturers in calculating systolic and diastolic BP. There may be errors in cuff pressure measurement and oscillometry, which may not accurately reflect the Korotkoff sounds heard by manual method.
A limitation of our study was the lack of a true gold standard such as intra-arterial BP measurement. It is known that cuff BP recordings tend to underestimate intra-arterial systolic pressure and overestimate diastolic pressure. 21 We found no evidence of such a systematic error between the Dinamap and mercury devices.
Although our sample size was similar to that rec-
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ommended by the BHS, a larger sample size would be useful for subgroup analysis. However, we believe that a larger sample size would be unlikely to change our conclusions.
In conclusion, we would recommend that the Dinamap 1846 XT not be used in clinical settings when accurate BP measurement is required. Future studies should assess the reliability and accuracy of automated BP devices in other settings such as outpatient clinics, intensive care units, and obstetrical wards. Our health district, like many others, is phasing out mercury manometers because of concerns about mercury toxicity. Moreover, nursing staff have turned to automatic systems to improve their efficiency. In our district, there is no scheduled maintenance for these devices and they are recalibrated only if a member of staff alerts the clinical engineering department. Therefore, it is likely that even greater measurement errors than we found occur on a regular basis. We recommend that all automated Dinamap readings be confirmed by a mercury manometer, or a recently calibrated aneroid instrument, for therapeutic decision making
